Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
Crossref DOI link: https://doi.org/10.1007/s00280-015-2767-y
Published Online: 2015-05-17
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matsuda, Chu
Munemoto, Yoshinori
Mishima, Hideyuki
Nagata, Naoki
Oshiro, Mitsuru
Kataoka, Masato
Sakamoto, Junichi
Aoyama, Toru
Morita, Satoshi
Kono, Toru
License valid from 2015-05-17